Starling Oncology, Inc. (STLN) stock
STLNNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as DFPH, STLNW
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/30
$3.20−0.20 (-5.88%)
Close on Nov 18, 2026Market cap $326.13MP/E –Yield –
Starling Oncology pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Starling Oncology's pe ratio was 245.8× on Apr 28, 2023.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Apr 28, 2023 | 245.8× | +126.8 |
| 2022 | Dec 30, 2022 | 119.0× | – |
See a number that looks wrong?